Caxias Do Sul, RIO%20GRANDE%20DO%20SULNCT06624059Now EnrollingIRB Ready

Lung Cancer Clinical Trial in Caxias Do Sul, RIO%20GRANDE%20DO%20SUL

Access cutting-edge lung cancer treatment through this clinical trial at a research site in Caxias Do Sul. Study-provided care at no cost to qualified participants.

Sponsored by Hoffmann-La Roche

Quick Self-Assessment

See if you qualify for this Caxias Do Sul location

Preparing your pre-screening questions...

Expert Care in Caxias Do Sul

Access lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lung cancer treatment provided free

Apply for This Caxias Do Sul Location

Check if you qualify for this lung cancer clinical trial in Caxias Do Sul, RIO%20GRANDE%20DO%20SUL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Caxias Do Sul

    Convenient for RIO%20GRANDE%20DO%20SUL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Caxias Do Sul site if eligible
  4. 4Begin participation

About This Lung Cancer Study in Caxias Do Sul

The objective of this study is to evaluate the efficacy and/or safety of multiple therapies in patients with early-stage resectable NSCLC. Cohort B1 is a phase II cohort that will evaluate the safety, and efficacy of alectinib in combination with up to four cycles of platinum-based chemotherapy in the adjuvant setting post complete surgical resection. Cohort B2 is a phase II cohort that will evaluate the efficacy and safety of perioperative alectinib in combination with chemotherapy in the neoad

Sponsor: Hoffmann-La Roche

Who Can Participate

Inclusion Criteria

Complete resection of the primary NSCLC with negative margins
Confirmed stage II to select stage IIIB (T3N2) NSCLC of non-squamous (adenocarcinoma) histology
Eastern cooperative oncology group (ECOG) performance status of 0 or 1 Inclusion Criteria Cohort B2:
Evaluation by the operating attending surgeon and involved medical oncologist prior to study enrollment to verify study eligibility for complete surgical resection with curative intent
Pathologically and/or histologically confirmed Stage II-IIIA and IIIB (T3N2 only) NSCLC of non-squamous (adenocarcinoma) histology Inclusion Criteria Cohorts B1 and B2:
Documented ALK fusion

Exclusion Criteria

NSCLC of squamous or mixed histology regardless of the presence of an ALK mutation
Prior exposure to any systemic anti-cancer therapy Exclusion Criteria Cohort B2:
NSCLC of squamous or mixed histology regardless of the presence of an ALK mutation
Known sensitivity to any comp

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Caxias Do Sul?

Yes, this clinical trial (NCT06624059) has an active research site in Caxias Do Sul, RIO%20GRANDE%20DO%20SUL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lung Cancer Treatment Options in Caxias Do Sul, RIO%20GRANDE%20DO%20SUL

If you're searching for lung cancer treatment options in Caxias Do Sul, RIO%20GRANDE%20DO%20SUL, this clinical trial (NCT06624059) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Caxias Do Sul research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Caxias Do Sul, RIO%20GRANDE%20DO%20SUL

See all lung cancer clinical trials recruiting in Caxias Do Sul — not just this study.

Browse Lung Cancer Trials in Caxias Do Sul →

Browse More Trials by Condition

Lung Cancer TrialsSmall Cell Lung Cancer TrialsNon-Small Cell Lung Cancer TrialsAll Conditions →

Ready to Join in Caxias Do Sul?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Caxias Do Sul, RIO%20GRANDE%20DO%20SUL